BRAIN Biotech AG BNN.DE

€2.40 €0.03 (1.23%) 1D

Last Updated: Apr 09, 12:00 AM·XETRA

BNN.DE Shariah Compliance

Screening Methodology: AAOIFI

lock image
UNLOCK FOR FREE

Last Updated: January 20, 2026

Report Source: 2025 3rd Quarter Report

Analyst's Ratings for BRAIN Biotech AG (BNN.DE)

Based on 9 analysts giving stock ratings to BRAIN Biotech AG in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
45
Buy
44
Hold
11
Sell
0
Strong Sell
0
BRAIN Biotech AG

BRAIN Biotech AG. Stock Analysis BNN.DE

Germany Materials Micro Cap Report:
BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 284 full-time employees. The company went IPO on 2016-02-09. Biotechnology Research and Information Network AG, is a Germany -based Company. The firm is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.
Read More

BRAIN Biotech AG (BNN.DE) Chart

Key Statistics of BRAIN Biotech AG (BNN.DE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€2.36€2.43

Today's Open

€2.43

Volume

4856.00

P/E Ratio (TTM)

-

52 Week Range

€1.81€3.89

Market Cap

50.69M

Avg. Volume

1055.50

Dividend Yield

-

Financial Metrics & Statements of BRAIN Biotech AG (BNN.DE)

Community-Curated Collections with BRAIN Biotech AG (BNN.DE) ( With BNN.DE )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for BRAIN Biotech AG (BNN.DE)

  • According to Musaffa’s Shariah screening methodology, BRAIN Biotech AG (BNN.DE) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.